Nerve excitability changes in critical illness polyneuropathy

Brain

Volumn 129, Issue 9, 2006, Pages 2461-2470

  Z'Graggen, W J ^a,b,d   Lin, C S Y ^a   Howard, R S ^b,c   Beale, R J ^c   Bostock, H ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

Axonal excitability; Intensive care; Membrane potential

Indexed keywords

ADULT; AGED; ARTICLE; BICARBONATE BLOOD LEVEL; CELL MEMBRANE DEPOLARIZATION; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL PROTOCOL; CONTROLLED STUDY; CORRELATION ANALYSIS; CRITICAL ILLNESS POLYNEUROPATHY; DEPOLARIZATION; ELECTROPHYSIOLOGY; FEMALE; FOLLOW UP; HUMAN; HYPERKALEMIA; HYPERPOLARIZATION; INTENSIVE CARE; KIDNEY FAILURE; LABORATORY TEST; MALE; MEDIAN NERVE; MUSCLE ACTION POTENTIAL; NERVE EXCITABILITY; NERVE FIBER MEMBRANE; NERVE STIMULATION; NERVE SUBEXCITABILITY; NERVE SUPEREXCITABILITY; POLYNEUROPATHY; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; REFRACTORY PERIOD; RESPIRATORY ACIDOSIS; STRENGTH; ACTION POTENTIAL; BLOOD; CELL MEMBRANE; CELL MEMBRANE POTENTIAL; CHRONIC DISEASE; ELECTROSTIMULATION; METHODOLOGY; MIDDLE AGED; NERVE FIBER; PATHOPHYSIOLOGY; PHYSIOLOGY; SKELETAL MUSCLE;

BICARBONATE; POTASSIUM;

ACIDOSIS, RESPIRATORY; ACTION POTENTIALS; ADULT; AGED; AXONS; BICARBONATES; CELL MEMBRANE; CHRONIC DISEASE; ELECTRIC STIMULATION; FEMALE; HUMANS; INTENSIVE CARE; KIDNEY FAILURE; MALE; MEDIAN NERVE; MEMBRANE POTENTIALS; MIDDLE AGED; MUSCLE, SKELETAL; POLYNEUROPATHIES; POTASSIUM;

EID: 33749258001     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awl191     Document Type: Article

References (27)

1. Berek K, Margreiter J, Willeit J, Berek A, Schmutzhard E, Mutz NJ. Polyneuropathies in critically ill patients: a prospective evaluation. Intensive Care Med 1996; 22: 849-55.
2. Bolton CF. Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit Care Med 1996; 24: 1408-16.
3. Bolton CF. Neuromuscular manifestations of critical illness. Muscle Nerve 2005; 32: 140-63.
4. Bolton CF, Gilbert JJ, Hahn AF, Sibbald WJ. Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry 1984; 47: 1223-31.
5. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644-55.
6. Bostock H, Cikurel K, Burke D. Threshold tracking techniques in the study of human peripheral nerve. Muscle Nerve 1998; 21: 137-58.
7. Bostock H, Walters RJ, Andersen KV, Murray NM, Taube D, Kiernan MC. Has potassium been prematurely discarded as a contributing factor to the development of uraemic neuropathy? Nephrol Dial Transplant 2004; 19: 1054-7.
8. Druschky A, Herkert M, Radespiel-Troger M, Druschky K, Hund E, Becker CM, et al. Critical illness polyneuropathy: clinical findings and cell culture assay of neurotoxicity assessed by a prospective study. Intensive Care Med 2001; 27: 686-93.
9. Goris RJ, te Boekhorst TP, Nuytinck JK, Gimbrere JS. Multiple-organ failure. Generalized autodestructive inflammation? Arch Surg 1985; 120: 1109-15.
10. Grafe P, Bostock H, Schneider U. The effects of hyperglycaemic hypoxia on rectification in rat dorsal root axons. J Physiol 1994; 480: 297-307.
11. Hund E. Myopathy in critically ill patients. Crit Care Med 1999; 27: 2544-7.
12. Hund E. Critical illness polyneuropathy. Curr Opin Neurol 2001; 14: 649-53.
13. Kiernan MC, Bostock H. Effects of membrane polarization and ischaemia on the excitability properties of human motor axons. Brain 2000; 123: 2542-51.
14. Kiernan MC, Burke D, Andersen KV, Bostock H. Multiple measures of axonal excitability: a new approach in clinical testing. Muscle Nerve 2000; 23: 399-409.
15. Kiernan MC, Guglielmi JM, Kaji R, Murray NM, Bostock H. Evidence for axonal membrane hyperpolarization in multifocal motor neuropathy with conduction block. Brain 2002a; 125: 664-75.
16. Kiernan MC, Walters RJ, Andersen KV, Taube D, Murray NM, Bostock H. Nerve excitability changes in chronic renal failure indicate membrane depolarization due to hyperkalaemia. Brain 2002b; 125: 1366-78.
17. Krishnan AV, Phoon RK, Pussell BA, Charlesworth JA, Bostock H, Kiernan MC. Altered motor nerve excitability in end-stage kidney disease. Brain 2005; 128: 2164-74.
18. Kuwabara S, Bostock H, Ogawara K, Sung JY, Kanai K, Mori M, et al. The refractory period of transmission is impaired in axonal Guillain-Barre syndrome. Muscle Nerve 2003; 28: 683-9.
19. Latronico N, Fenzi F, Recupero D, Guarneri B, Tomelleri G, Tonin P, et al. Critical illness myopathy and neuropathy. Lancet 1996; 347: 1579-82.
20. Latronico N, Peli E, Botteri Latronico M. Critical illness myopathy and neuropathy. Curr Opin Crit Care 2005; 11: 126-32.
21. Leijten FS, De Weerd AW, Poortvliet DC, De Ridder VA, Ulrich C, Harink-De Weerd JE. Critical illness polyneuropathy in multiple organ dysfunction syndrome and weaning from the ventilator. Intensive Care Med 1996; 22: 856-61.
22. Lemaire F. Difficult weaning. Intensive Care Med 1993; 19 (Suppl 2): S69-73.
23. Rich MM, Bird SJ, Raps EC, McCluskey LF, Teener JW. Direct muscle stimulation in acute quadriplegic myopathy. Muscle Nerve 1997; 20: 665-73.
24. Sander HW, Golden M, Danon MJ. Quadriplegic areflexic ICU illness: selective thick filament loss and normal nerve histology. Muscle Nerve 2002; 26: 499-505.
25. Schwarz JR, Reid G, Bostock H. Action potentials and membrane currents in the human node of Ranvier. Pflugers Arch 1995; 430: 283-92.
26. Witt NJ, Zochodne DW, Bolton CF, Grand'Maison F, Wells G, Young GB, et al. Peripheral nerve function in sepsis and multiple organ failure. Chest 1991; 99: 176-84.
27. Zochodne DW, Bolton CF, Wells GA, Gilbert JJ, Hahn AF, Brown JD, et al. Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. Brain 1987; 110: 819-41.